Hishikawa-Itoh Y, Sugie I, Kato H, Iwanaga S
J Biochem. 1982 Oct;92(4):1129-40. doi: 10.1093/oxfordjournals.jbchem.a134029.
A factor, named SK-potentiator, which is known to potentiate the activation of plasminogen by streptokinase (SK), was isolated from human plasma. The procedures consisted of column chromatographies on DEAE-Sephadex A-50 and heparin-agarose, followed with gel-filtration on a Sepharose 6B column and affinity chromatography on a lysine-Sepharose 4B column. The isolated SK-potentiator markedly potentiated the rate of activation of plasminogen by streptokinase. However, it did not show a potentiating effect on the activation of plasminogen by urokinase or on the plasmin activity. SK-potentiator showed a similar mobility to that of fibrinogen on both SDS-polyacrylamide gel and agarose gel electrophoresis, and cross-reacted with anti-fibrinogen antiserum. The amino acid composition of SK-potentiator was very close to that of human fibrinogen, although the content of serine and threonine was significantly lower. SK-potentiator showed a single band with a molecular weight of 300,000 on SDS-gel electrophoresis in the absence of 2-mercaptoethanol. In the presence of 2-mercaptoethanol, it showed two major bands with molecular weights of 53,000 and 48,000, respectively, which corresponded to the B beta chain and gamma chain of fibrinogen. To establish further that the isolated SK-potentiator may be one of the fibrinogen degradation products (FDP), human fibrinogen was digested with plasmin and the SK-potentiator activity generated in the course of the digestion was measured. As a result, the SK-potentiator activity was found to initially increase and then decrease with incubation time, suggesting that an early FDP has the ability to potentiate the SK-mediated activation of plasminogen. The early FDP was then isolated by gel-filtration on a column of Sepharose 6B and it was found that the SK-potentiator activity was associated with the early FDP. Moreover, the early FDP showed the same electrophoretic mobility as the isolated SK-potentiator on SDS-gel electrophoresis and their amino acid compositions were quite similar to each other. From these results, the SK-potentiator was identified as the early FDP.
从人血浆中分离出一种名为SK增强剂的因子,已知它能增强链激酶(SK)对纤溶酶原的激活作用。实验步骤包括在DEAE - 葡聚糖A - 50和肝素 - 琼脂糖上进行柱色谱,随后在琼脂糖6B柱上进行凝胶过滤以及在赖氨酸 - 琼脂糖4B柱上进行亲和色谱。分离出的SK增强剂显著增强了链激酶对纤溶酶原的激活速率。然而,它对尿激酶激活纤溶酶原或对纤溶酶活性没有增强作用。SK增强剂在SDS - 聚丙烯酰胺凝胶和琼脂糖凝胶电泳上显示出与纤维蛋白原相似的迁移率,并与抗纤维蛋白原抗血清发生交叉反应。SK增强剂的氨基酸组成与人类纤维蛋白原非常接近,尽管丝氨酸和苏氨酸的含量明显较低。在没有2 - 巯基乙醇的情况下,SK增强剂在SDS - 凝胶电泳上显示出一条分子量为300,000的条带。在有2 - 巯基乙醇的情况下,它显示出两条主要条带,分子量分别为53,000和48,000,分别对应于纤维蛋白原的Bβ链和γ链。为了进一步确定分离出的SK增强剂可能是纤维蛋白原降解产物(FDP)之一,用纤溶酶消化人纤维蛋白原并测量消化过程中产生的SK增强剂活性。结果发现,SK增强剂活性最初随孵育时间增加然后降低,这表明早期FDP具有增强SK介导的纤溶酶原激活的能力。然后通过在琼脂糖6B柱上进行凝胶过滤分离出早期FDP,发现SK增强剂活性与早期FDP相关。此外,早期FDP在SDS - 凝胶电泳上显示出与分离出的SK增强剂相同